Difference between revisions of "Talk:Bioblast 2022"
From Bioblast
Line 35: | Line 35: | ||
|- | |- | ||
|- | |- | ||
|Β || || 12:00 ||[[Chicco | |Β || || 12:00 ||[[Chicco 2022 MitoFit |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]] || [[Chicco Adam J]] | ||
|- | |- | ||
|- | |- | ||
Line 41: | Line 41: | ||
|- | |- | ||
|- | |- | ||
|Β || || 12:15 || || | |Β || || 12:15 || [[Axelrod 2022 Abstract Bioblast |Segmental regulation of intestinal mitochondrial function]] || [[Axelrod Christopher L]] | ||
|- | |- | ||
|- | |- | ||
|Β || || 12:20 || | |Β || || 12:20 || [[Granata 2022 Abstract Bioblast |Exercise training-induced enhancement of electron flow to the OXPHOS system is more important than increasing the OXPHOS machinery content to improve ATP generation in human skeletal muscle]] || [[Granata Cesare]] | ||
|- | |- | ||
|- | |- | ||
|Β || || 12: | |Β || || 12:25 || [[Pilot-Storck 2022 Abstract Bioblast |Hacd1 and Hacd2 genes control mitochondrial energetic efficiency through the modulation of mitochondrial membranes phospholipid composition]] || Pilot-Storck F | ||
|- | |- | ||
|- | |- |
Revision as of 09:18, 18 May 2022
Program
2022-06-29 Day 1 of scientific presentations
2022-06-30 Day 2 of scientific presentations